lower
respiratori
tract
infect
lrti
common
particularli
first
year
mani
case
lrti
caus
virus
mild
cours
unless
complic
bacteri
howev
case
proceed
sever
cours
earli
diagnosi
recognit
diseas
sever
necessari
optim
care
mani
inflammatori
marker
develop
serv
purpos
erythrocyt
sediment
rate
esr
protein
crp
level
procalcitonin
pct
pentraxin
novel
biomark
behav
protein
blood
level
low
normal
condit
ngml
human
ngml
children
rapidli
increas
plasma
inflamm
eg
sepsi
endotoxin
shock
inflammatori
condit
releas
respons
microbi
recognit
bind
specif
pathogen
fungi
bacteria
previou
studi
found
plasma
level
could
use
diagnos
sever
commun
acquir
pneumonia
higher
sensit
compar
crp
also
correl
length
hospit
anoth
studi
found
high
concentr
help
differenti
parapneumon
effus
howev
studi
investig
valu
viral
infect
common
caus
lrti
children
aim
studi
evalu
use
clinic
marker
lrti
examin
correl
biomark
crp
pct
enrol
consecut
patient
lrti
admit
ward
emerg
depart
outpati
depart
use
criteria
patient
fever
cough
fast
respiratori
rate
age
chest
rhonchi
crepit
auscult
children
exclud
receiv
antibiot
day
preced
admiss
suffer
underli
chronic
diseas
eg
anatom
abnorm
respiratori
tract
immunolog
deficit
progress
neurolog
condit
psychomotor
retard
congenit
heart
diseas
hemoglobinopathi
sever
malnutrit
concurr
infect
record
data
fever
durat
peak
temperatur
admiss
durat
fever
admiss
respiratori
rate
heart
rate
oxygen
satur
upon
admiss
durat
oxygen
supplement
durat
hospit
stay
upon
admiss
total
white
blood
cell
wbc
count
esr
crp
level
measur
blood
sampl
medic
treatment
multiplex
respiratori
viru
polymeras
chain
reaction
pcr
perform
use
nasal
swab
blood
sampl
measur
pct
cytokin
chemokin
place
tube
contain
edta
immedi
centrifug
store
assay
perform
studi
complet
admiss
patient
month
age
receiv
mgkgday
intraven
amoxicillin
sodium
potassium
clavulan
moxicl
inject
daewoong
pharm
seoul
korea
patient
month
year
age
receiv
mgkgday
intraven
amoxicillin
sodium
potassium
clavulan
patient
year
age
receiv
mg
intraven
amoxicillin
sodium
potassium
clavulan
patient
posit
result
upon
mycoplasma
pneumonia
pcr
receiv
mgkgday
oral
clarithromycin
klaricid
dri
syrup
abbott
korea
limit
seoul
korea
children
medic
diagnosi
lrti
admit
seoul
st
mari
hospit
may
novemb
enrol
enrol
conduct
pediatr
pulmonologist
institut
review
board
seoul
st
mari
hospit
approv
studi
protocol
written
inform
consent
obtain
parent
guardian
assent
obtain
invit
children
resplex
ii
assay
qiagen
hilden
germani
simultan
target
virus
respiratori
syncyti
viru
rsv
human
rhinoviru
hrhv
influenza
viru
iv
human
metapneumoviru
hmpv
human
coronavirus
hcov
parainfluenza
viru
piv
adenoviru
adv
human
bocaviru
hbov
rna
test
singl
reaction
use
resplex
ii
assay
follow
protocol
manufactur
describ
quantif
five
cytokin
interleukin
il
interferon
ifn
tumor
necrosi
factor
tnf
four
chemokin
granulocyt
stimul
factor
mig
interferon
gamma
induc
sera
perform
pro
human
cytokin
assay
laboratori
inc
hercul
ca
assay
carri
accord
manufactur
instruct
pneumonia
specimen
obtain
throat
swab
dna
extract
subcultur
clinic
specimen
centrifug
sampl
min
refriger
minicentrifug
digest
pellet
proteinas
k
mgml
lysi
buffer
hr
proteinas
k
inactiv
incub
min
use
binaxnow
streptococcu
pneumonia
antigen
card
binax
portland
test
urinari
pneumococc
antigen
test
detect
polysaccharid
present
cell
wall
pneumococc
strain
urin
concentr
fold
select
ultrafiltr
pm
minicon
concentr
millipor
bedford
result
consid
qualit
either
posit
neg
use
human
elisa
kit
boster
biolog
technolog
co
ltd
fremont
ca
measur
plasma
concentr
blood
sampl
plasma
sampl
directli
transfer
strip
well
elisa
plate
subsequ
incub
hr
room
temperatur
three
wash
step
detect
antibodi
ad
reaction
system
incub
hr
room
temperatur
antibodi
bind
detect
horseradish
peroxidas
develop
substrat
solut
next
reaction
stop
optic
densiti
determin
micropl
reader
set
nm
wavelength
correct
set
nm
sampl
result
calcul
standard
curv
gener
dilut
known
amount
recombin
protein
standard
sampl
assay
duplic
pct
measur
perform
use
amplifi
cryptat
emiss
technolog
assay
kryptor
pct
brahm
ag
hennigsdorf
germani
function
assay
sensit
gl
fourfold
normal
mean
coeffici
variat
concentr
ngml
respect
assay
time
less
min
result
routin
avail
within
hr
pediatr
earli
warn
score
pew
easili
score
tool
base
five
domain
behavior
cardiovascular
statu
respiratori
statu
nebul
use
persist
postsurg
vomit
tool
support
algorithm
respons
base
critic
pew
defin
total
score
score
pew
domain
reflect
critic
valu
requir
consult
patient
score
accord
pew
upon
admiss
statist
analys
perform
use
sa
softwar
version
sa
institut
inc
cari
nc
continu
variabl
express
mean
se
number
n
percentag
express
categor
variabl
compar
level
differ
type
viral
infect
perform
continu
variabl
follow
parametr
distribut
wilcoxon
test
use
compar
categor
variabl
linear
regress
analysi
appli
correl
clinic
laboratori
variabl
lrti
patient
receiv
oper
characterist
roc
curv
gener
predict
hospit
stay
day
day
accord
crp
pct
level
statist
signific
defin
p
test
total
patient
includ
studi
mean
age
studi
popul
year
male
regard
clinic
featur
patient
mean
durat
fever
admiss
day
mean
peak
temperatur
admiss
mean
hospit
stay
day
mean
pew
score
regard
laboratori
data
mean
esr
mmhr
mean
wbc
count
cell
mean
number
neutrophil
cell
mean
crp
level
mgdl
mean
pct
level
ngml
mean
level
ngml
tabl
within
studi
popul
caus
agent
found
patient
posit
pcr
result
rsv
frequent
isol
agent
case
two
case
iv
eight
case
adv
eight
case
hmpv
ten
case
piv
ten
case
hrhv
two
case
hcov
nine
case
hbov
four
case
pneumonia
infect
three
case
pneumonia
infect
tabl
signific
differ
level
case
type
caus
agent
compar
caus
agent
fig
infect
group
case
superinfect
case
without
superinfect
signific
differ
level
accord
superinfect
data
shown
level
show
signific
correl
pct
level
level
crp
tabl
level
show
signific
correl
peak
temperatur
durat
fever
admiss
well
level
pct
level
show
signific
correl
peak
temperatur
durat
fever
admiss
well
hospit
stay
pct
also
show
signific
correl
level
crp
level
show
signific
correl
durat
fever
admiss
esr
total
wbc
count
neutrophil
count
tabl
howev
pct
crp
level
show
signific
correl
durat
fever
admiss
respiratori
rate
heart
rate
oxygen
satur
durat
oxygen
supplement
pct
crp
also
show
signific
correl
tabl
assess
abil
inflammatori
marker
pct
crp
abil
predict
hospit
stay
day
day
pct
crp
significantli
predict
hospit
stay
day
addit
crp
significantli
predict
hospit
stay
day
howev
pct
level
significantli
predict
hospit
stay
day
tabl
studi
aim
evalu
use
inflammatori
marker
lrti
examin
correl
biomark
crp
pct
found
signific
differ
level
case
type
viral
infect
caus
agent
level
show
signific
correl
peak
temperatur
durat
fever
admiss
well
level
pct
level
show
signific
correl
peak
temperatur
durat
fever
admiss
well
durat
hospit
stay
pct
also
show
signific
correl
level
crp
level
show
signific
correl
durat
fever
admiss
esr
total
wbc
count
neutrophil
count
pct
level
significantli
predict
hospit
stay
day
level
known
increas
variou
diseas
kidney
diseas
cardiovascular
diseas
acut
respiratori
distress
found
level
reflect
diseas
sever
children
lrti
show
signific
correl
peak
temperatur
durat
fever
admiss
result
similar
report
previou
studi
found
plasma
level
could
use
diagnos
sever
commun
acquir
pneumonia
also
found
pct
level
reflect
diseas
sever
prognosi
children
lrti
find
support
previou
studi
report
similar
lack
correl
clinic
sign
diseas
sever
might
age
studi
popul
diseas
categori
differ
previou
studi
involv
rather
seriou
diseas
acut
respiratori
distress
syndrom
cardiovascular
diseas
sepsi
differ
level
found
infect
caus
agent
one
possibl
explan
find
might
due
limit
nasopharyng
swab
presum
even
patient
detect
virus
might
actual
studi
also
found
level
vari
depend
type
viru
caus
infect
act
part
innat
immun
system
pattern
recognit
molecul
also
involv
resist
viral
bind
human
murin
cytomegaloviru
hcmv
mcmv
respect
reduc
viral
infect
dendrit
cell
accordingli
mice
present
higher
suscept
infect
mice
viral
titer
reduc
upon
treatment
recombin
moreov
protect
mice
aspergillu
fumigatu
superinfect
enhanc
product
dendrit
cell
cell
final
human
murin
bind
influenza
viru
interact
viral
hemagglutinin
glycoprotein
sialic
acid
residu
present
inhibit
hemagglutin
viral
neuraminidas
activ
neutral
viru
treatment
recombin
reduc
mortal
viral
studi
need
discov
differenti
effect
differ
type
viru
vivo
studi
found
level
correl
level
result
similar
previou
studi
found
correl
patient
acut
pancreat
obstruct
sleep
howev
show
signific
correl
current
studi
differ
previou
studi
found
produc
respons
proinflammatori
stimuli
includ
microbi
moieti
receptor
tlr
limit
studi
first
studi
popul
limit
mild
case
lrti
case
requir
intens
care
mean
pew
score
one
case
score
secondli
distribut
caus
agent
concentr
select
virus
recent
studi
examin
level
induc
sputum
asthmat
patient
anoth
studi
investig
use
level
bronchoalveolar
lavag
fluid
discrimin
microbiolog
confirm
pneumonia
mechan
ventil
studi
involv
local
level
lrti
would
interest
conclus
reflect
diseas
sever
lrti
children
fail
act
prognost
marker
studi
order
evalu
use
biomark
mild
lrti
would
use
